Prostate Cancer - Results from #28520

Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer - Abstract March 8, 2011

Androgen regulation of prostate cancer: Where are we now? - Abstract March 8, 2011

Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: A review - Abstract March 8, 2011

PSA-based prostate cancer screening: The role of active surveillance and informed and shared decision making - Abstract March 8, 2011

The effect of Pro-Qura case volume on post-implant prostate dosimetry - Abstract March 8, 2011

Patient-specific quality assurance for prostate cancer patients receiving spot scanning proton therapy using single-field uniform dose - Abstract March 8, 2011

Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer - Abstract March 8, 2011

A renaissance in the medical treatment of advanced prostate cancer - Abstract March 7, 2011

A prospective evaluation of conventional cystography for detection of urine leakage at the vesicourethral anastomosis site after radical prostatectomy based on computed tomography - Abstract March 7, 2011

Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 Cohort Study - Abstract March 7, 2011

Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer - Abstract March 7, 2011

HDR monotherapy for prostate cancer: A simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation - Abstract March 7, 2011

Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125 - Abstract March 7, 2011

Active surveillance for prostate cancer: Usefulness of endorectal MR at 1.5 Tesla with pelvic phased array coil in detecting significant tumors - Abstract March 7, 2011

Intact and internally cleaved free prostate-specific antigen in patients with prostate cancer with different pathologic stages and grades - Abstract March 7, 2011

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study - Abstract March 7, 2011

Prostate T(1) quantification using a magnetization-prepared spiral technique - Abstract March 4, 2011

Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy - Abstract March 4, 2011

Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: Observations with tandutinib - Abstract March 4, 2011

Prospective evaluation of (11)C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases - Abstract March 4, 2011

Page 1427 of 1437